ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,964, issued on April 14, was assigned to Medizinische Hochschule Hannover (Hannover, Germany).
"Compound for treatment of heart failure" was invented by Thomas Thum (Hannover, Germany), Sandor Batkai (Hannover, Germany) and Ariana Foinquinos (Amsterdam).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to an oligonucleotide which is an effective inhibitor of microRNA miR-132 and its use in medicine, particularly in the prevention or treatment of cardiac and/or fibrotic disorders."
The patent was filed on Nov. 17, 2021, under Application No. 17/529,119.
*For further information, including images, charts and tables, please ...